Safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma: a systematic review and meta-analysis

Taylor and Francis Group, Expert Opinion on Drug Safety, 10(19), p. 1329-1338, 2020

Journal article published in 2020 by Francesco Massari, Veronica Mollica, Alessandro Rizzo, Laura Cosmai

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by